Furthermore, telomerase inhibition decreases AFP expression and secretion likely through the PI3K/Akt/mTOR/STAT3 pathway in the HCC cell lines HepG2/C3A and PLC/PRF/5, which express telomerase and AFP. Here, AFP is linked to hepatocellular carcinoma.